A new "breakthrough" in research from the Centers for Disease Control and Prevention has brought cutting agent vitamin E acetate back under the microscope as the tally of people sickened from vaping-related lung injuries surged past 2,000.

New research from the agency, released on Friday, examined lung fluid samples from victims of e-cigarette, or vaping, product use associated lung injury (EVALI) and found vitamin E acetate in 100 percent of samples from 29 patients across 10 states. Previous testing had only found vitamin E acetate in vape liquids, rather than in the biological tissue of patients impacted.

"These new findings are significant because for the first time, we have detected a potential toxin of concern, vitamin E acetate, in biologic samples from patients," CDC Deputy Director Dr. Anne Schuchat told reporters on a call on Friday. "These findings provide direct evidence of vitamin E acetate at the primary site of injury within the lung, and the samples reflect patients from states across the country.

Vitamin E Acetate is a common vitamin supplement found in cosmetics and food that is used as a thinning agent in (mostly illicit) vape liquids. Officials said it is still safe to consume this supplement in food or use it on skin, but that inhaling the product may have adverse effects.

Officials in some states, like New York, had previously suspected the thinning agent was to blame in the rash of illnesses, but the FDA and CDC have maintained more cautious language. Even on the back of Friday's reports, Schuchat emphasized that "these findings do not rule out other possible compounds or ingredients that may be causing these lung injuries."

"These findings tell us what entered the lung of some patients with EVALI," she added. "Although vitamin E acetate was universally detected in these 29 ... samples, additional studies are needed to determine whether a causal link exists between the exposure and EVALI."

The CDC also tested samples for plant oils, petroleum distillates, MCT oil, and terpenes. THC and its metabolites were found in lung samples from 23 of 28 patients — even three patients who said they did not use THC products.

"THC is not something we expect to find hanging around in the lung fluids," Dr. Jim Pirkle of the CDC's Environmental Health Lab, said on a call with reporters, emphasizing that urine is typically the place THC and its metabolites are found.

The CDC said Friday's findings reinforced the agency's previous advice to the public to "not use e-cigarette or vaping products that contain THC," especially those obtained illicitly.

Illinois researchers who compared survey results from THC users and from EVALI patients and found that EVALI victims were nine times more likely to have obtained their THC vape products informally — from friends, family, or the illicit market — than average THC vape users. Dr. Jennifer Layden, chief medical officer and state epidemiologist at the Illinois Department of Public Health, added that none of the EVALI victims in Illinois had purchased their products at licensed medical cannabis dispensaries.

But Schuchat said it is still too soon to exonerate licensed vape products and retail shops, considering anecdotal reports remain of illnesses related to products purchased at legal dispensaries, differences in the severity of regulations that govern additives state-by-state, and the severity of the illness.

"The majority of what we are seeing right now is pointing to informal spaces," she added. "We have cases now from 49 states, many of which have legal marijuana markets. The data are pointing toward the illicit supply, but this is a very serious disease which can be fatal, and I don't think we know enough yet to completely take dispensaries out of the question."

The CDC reported on Thursday that, as of Nov. 5, 2,051 people have fallen ill and 39 have died from EVALI across 49 states, Puerto Rico, and the U.S. Virgin Islands. That tally represents a jump of 163 illnesses and two deaths since last week's report.

"The trend in cases appears to be downward, but we understand that some states are still hard hit and this continues to be a very active investigation," Schuchat said.

Although THC vape products have been implicated in a majority of cases of EVALI, nicotine vapes have not been ruled out, and the CDC still recommends the public consider from refraining from use of all vapes or e-cigarettes.

Share:
More In Business
OpenAI names Slack CEO Dresser as first chief of revenue
OpenAI has appointed Slack CEO Denise Dresser as its first chief of revenue. Dresser will oversee global revenue strategy and help businesses integrate AI into daily operations. OpenAI CEO Sam Altman recently emphasized improving ChatGPT, which now has over 800 million weekly users. Despite its success, OpenAI faces competition from companies like Google and concerns about profitability. The company earns money from premium ChatGPT subscriptions but hasn't ventured into advertising. Altman had recently announced delays in developing new products like AI agents and a personal assistant.
Trump approves sale of more advanced Nvidia computer chips used in AI to China
President Donald Trump says he will allow Nvidia to sell its H200 computer chip used in the development of artificial intelligence to “approved customers” in China. Trump said Monday on his social media site that he had informed China’s leader Xi Jinping and “President Xi responded positively!” There had been concerns about allowing advanced computer chips into China as it could help them to compete against the U.S. in building out AI capabilities. But there has also been a desire to develop the AI ecosystem with American companies such as chipmaker Nvidia.
Trump says Netflix deal to buy Warner Bros. ‘could be a problem’ because of size of market share
President Donald Trump says a deal struck by Netflix last week to buy Warner Bros. Discovery “could be a problem” because of the size of the combined market share. The Republican president says he will be involved in the decision about whether federal regulators should approve the deal. Trump commented Sunday when he was asked about the deal as he walked the red carpet at the Kennedy Center Honors. The $72 billion deal would bring together two of the biggest players in television and film and potentially reshape the entertainment industry.
What to know about changes to Disney parks’ disability policies
Disney's changes to a program for disabled visitors are facing challenges in federal court and through a shareholder proposal. The Disability Access Service program, which allows disabled visitors to skip long lines, was overhauled last year. Disney now mostly limits the program to those with developmental disabilities like autism who have difficulty waiting in lines. The changes have sparked criticism from some disability advocates. A shareholder proposal submitted by disability advocates calls for an independent review of Disney's disability policies. Disney plans to block this proposal, claiming it's misleading. It's the latest struggle by Disney to accommodate disabled visitors while stopping past abuses by some theme park guests.
Load More